Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial

BACKGROUND: Migraine is a recurrent headache disorder that has a still unclear pathophysiology, involving several circuits of both the central and peripheral nervous system. Monoclonal antibodies acting on the calcitonin gene-related (CGRP) pathway (CGRP-MAbs) are the first drugs specifically design...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornello, Raffaele, Rosignoli, Chiara, Caponnetto, Valeria, Pistoia, Francesca, Ferrara, Michele, D'Atri, Aurora, Sacco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127506/
https://www.ncbi.nlm.nih.gov/pubmed/35620782
http://dx.doi.org/10.3389/fneur.2022.890364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127506/
https://www.ncbi.nlm.nih.gov/pubmed/35620782
http://dx.doi.org/10.3389/fneur.2022.890364

Ejemplares similares